| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
October Pharma S.A.E Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م100.00 |
| 52 Week High | ج.م120.00 |
| 52 Week Low | ج.م80.00 |
| Beta | -0.21 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | 109.95% |
| 5 Year Change | 177.09% |
| Change since IPO | 2,005.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| OCPH | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | 1.4% |
| 1Y | 0% | 28.2% | 62.5% |
Return vs Industry: OCPH underperformed the EG Pharmaceuticals industry which returned 28.2% over the past year.
Return vs Market: OCPH underperformed the EG Market which returned 62.5% over the past year.
Price Volatility
| OCPH volatility | |
|---|---|
| OCPH Average Weekly Movement | 0% |
| Pharmaceuticals Industry Average Movement | 4.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in EG Market | 9.0% |
| 10% least volatile stocks in EG Market | 3.3% |
Stable Share Price: OCPH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OCPH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | n/a | www.octoberpharma.com |
October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides its products in solid forms, such as tablets, capsules, and powders; liquid forms comprising syrups, drops, solutions, and sprays; creams and suppositories; soft gelatin capsules; and ampoules and vials. October Pharma S.A.E was founded in 1987 is based in Cairo, Egypt.
October Pharma S.A.E Fundamentals Summary
| OCPH fundamental statistics | |
|---|---|
| Market cap | ج.م1.20b |
| Earnings (TTM) | ج.م157.30m |
| Revenue (TTM) | ج.م1.07b |
7.6x
P/E Ratio1.1x
P/S RatioIs OCPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OCPH income statement (TTM) | |
|---|---|
| Revenue | ج.م1.07b |
| Cost of Revenue | ج.م554.52m |
| Gross Profit | ج.م518.89m |
| Other Expenses | ج.م361.59m |
| Earnings | ج.م157.30m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 13.11 |
| Gross Margin | 48.34% |
| Net Profit Margin | 14.65% |
| Debt/Equity Ratio | 54.5% |
How did OCPH perform over the long term?
See historical performance and comparison